The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

NCT03262727 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Arthritic Psoriasis
Psoriasis
Inflammatory Bowel Diseases

Interventions

DRUG: BMS-986165
DRUG: Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol)

Sponsor

Bristol-Myers Squibb